Company intelligence / Profile preview

Crossroads Treatment Centers

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Crossroads Treatment Centers operates over 100 outpatient centers across nine U.S. states providing evidence-based medication-assisted treatment and behavioral therapies for individuals with substance use disorders. Their approach combines FDA-approved medications with counseling and peer support. The company has served tens of thousands of patients since its founding in 2005 and is recognized for its focus on health equity and rapid access to care through innovations like Instant Intake®. Outcomes include improved patient lives and increased access to life-saving treatments

Therapeutic areas: Psychiatry
Modalities: Small moleculeNon-pharmacological therapyDevice
Industry: Non-Academic Healthcare

Partnerships

Revelstoke Capital PartnersCaisse de dépôt et placement du Québec (CDPQ)

Beyond the preview

Go deeper on Crossroads Treatment Centers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crossroads Treatment Centers.

Explore the full profile